Filing Details
- Accession Number:
- 0001209191-13-055068
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-03 19:00:20
- Reporting Period:
- 2013-11-29
- Filing Date:
- 2013-12-03
- Accepted Time:
- 2013-12-03 19:00:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1162194 | Fluidigm Corp | FLDM | Laboratory Analytical Instruments (3826) | 770513190 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222642 | C Robert Jones | Fluidigm Corporation 7000 Shoreline Court, Suite 100 South San Francisco CA 94080 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-29 | 2,405 | $4.45 | 2,405 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-29 | 1,095 | $4.45 | 3,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-29 | 3,500 | $32.01 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-11-29 | 2,405 | $0.00 | 2,405 | $4.45 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-11-29 | 1,095 | $0.00 | 1,095 | $4.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-04-23 | No | 4 | M | Direct | |
| 10,465 | 2018-04-23 | No | 4 | M | Direct |
Footnotes
- The sales reported by Mr. Jones were effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2013.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $31.84 to $32.31 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The shares subject to the Option fully vested on May 1, 2012.
- The shares subject to the Option fully vested on March 31, 2012.
Billionaire Hedge Funds
